Amphista Therapeutics Ltd
1 clinical trials · Sponsor
◉ Watch Amphista Therapeutics Ltd
| Record | Firm | Date |
|---|---|---|
| Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML (NCT07723703) | Amphista Therapeutics Ltd | 2026-09-01 |
Track Amphista Therapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.